Ukubwa wa maandishi
safe2choose

Aina za Tembe za Utoaji Mimba na Chapa Zinazoaminika Ulimwenguni

Illustration of a map, marking the different medical abortion pills available in different regions around the world.

Mifepristone na Misoprostol vyote ni tembe za utoaji mimba zinazopatikana chini ya majina mengi ya chapa duniani kote. Tunatumaini kuwa mwongozo huu kuhusu chapa mbalimbali za tembe utakupa taarifa zote unazohitaji; hata hivyo, iwapo una maswali zaidi, tafadhali wasiliana moja kwa moja na mshauri wetu kupitia barua pepe au gumzo la moja kwa moja; tutafurahi kukusaidia.

TEMBE ZA UTOAJI MIMBA

Ni Aina Gani Tofauti za Tembe za Utoaji Mimba na Zinazofanya Kazi Vipi?

Hands with blue nails grabbing a mifepristone pill from a blister of a combipack containing one mifepristone and four misoprostol pills.

Kuna aina mbili za vidonge vya kutoa mimba na kila moja hufanya kazi kwa njia tofauti. Mifepristone huzuia homoni inayohitajika ili ujauzito ukue, ilhali misoprostol hufanya kwa kulegeza na kufungua mlango wa kizazi (seviksi), kisha kusababisha mfuko wa uzazi kusinyaa na kutoa ujauzito. Zote, yaani mchanganyiko wa mifepristone na misoprostol au misoprostol pekee ni njia salama na zenye ufanisi. Hata hivyo, iwapo zinapatikana na zinaweza kumudu kifedha, mchanganyiko wa mifepristone na misoprostol una ufanisi zaidi. Kuna chapa nyingi tofauti za tembe za utoaji mimba sokoni. Upatikanaji wake mara nyingi hutegemea unakoishi.

UBORA WA TEMBE NA MAPENDEKEZO

Je, Chapa Zote za Tembe za Utoaji Mimba Hufanya Kazi Vivyo Hivyo?

Baadhi ya chapa huuzwa kama vifurushi vya mchanganyiko vyenye mifepristone na misoprostol, huku zingine zikitolewa kama dawa tofauti. safe2choose ina mwongozo wa kina wa jinsi ya kutumia vidonge vya utoaji mimba kwa usalama, ikihusisha mpango wa mchanganyiko na matumizi ya misoprostol pekee. Utafiti wa hivi karibuni umeonyesha kwamba ni takribani asilimia 10 pekee ya chapa za misoprostol na asilimia 25 ya vifurushi vya mchanganyiko katika nchi 44 ndivyo vinavyokidhi viwango vya ubora vya kimataifa, kama vile WHO Prequalification (WHO-PQ) au idhini kutoka kwa Stringent Regulatory Authority (SRA). Hii inamaanisha kwamba, ingawa tembe nyingi zimesajiliwa, bado ni vigumu kupata dawa salama na yenye ufanisi. Baadhi ya chapa za misoprostol zinaweza kukosa kiwango sahihi cha kiambato kinachofanya kazi au kupoteza nguvu zikihifadhiwa vibaya. Chapa zilizoidhinishwa na wasimamizi wanaoaminika kama Medabon, Mariprist, au Mifegyne mara nyingi huwa na ubora wa juu na wa kudumu.

Mifepristone kwa kawaida huwa imara zaidi, lakini misoprostol ni nyeti kwa joto na unyevunyevu, jambo linaloweza kuathiri ufanisi wake. Ndiyo maana ni muhimu kupata tembe kutoka nyanzo zinazoaminika na kuziweka kwenye vifungashio vyake vya asili vilivyofungwa vizuri, mbali na unyevunyevu. Jifunze zaidi kuhusu tembe za utoaji mimba zinazopatikana nchini kwako au jinsi ya kupata tembe za kutoa mimba mtandaoni na nje ya mtandao. Unaweza kuwasiliana na timu yetu kwa usaidizi wowote wakati wowote tupo hapa kwa ajili yako!

CHAPA ZA TEMBE ZA UTOAJI MIMBA

Kuna Chapa Nyingapi za Tembe za Utoaji Mimba Duniani?

Three medication boxes are illustrated: a Combipack of mifepristone and misoprostol, mifepristone box, and misoprostol box.

Kuna zaidi ya chapa 78 tofauti za tembe za utoaji mimba duniani kote. Umaarufu wa chapa hutegemea eneo. Kwa mfano, Cytotec ndiyo chapa maarufu zaidi duniani, lakini nchini India, chapa maarufu zaidi ni Unwanted-Kit. Hapa kuna baadhi ya chapa maarufu za tembe za utoaji mimba:

UPATIKANAJI WA TEMBE ZA UTOAJI MIMBA DUNIANI

Upatikanaji wa Tembe Kulingana na Eneo

Shirika la Afya Duniani limeorodhesha mifepristone na misoprostol kama dawa muhimu [7] kwa sababu ni salama na zina ufanisi wa kukomesha ujauzito.

Upatikanaji wa dawa hizi umeimarika katika muongo uliopita, lakini bado kuna mapengo makubwa. Mapitio ya hivi karibuni ya nchi 44 zenye kipato cha chini na cha kati [10] yamebaini kwamba bidhaa za misoprostol pekee zinapatikana kwa wingi, huku mifepristone na vifurushi vya mchanganyiko vikiwa vigumu kupatikana. Ubora pia ni suala la kuzingatia. Hata pale vidonge vinapopatikana, masoko rasmi na yasiyo rasmi mara zote havihakikishi dawa salama na bora, jambo linaloweza kuhatarisha afya ya watu. Bei za tembe za utoaji mimba hutofautiana sana kulingana na eneo. Katika Amerika ya Kusini na Afrika, bei huwa juu na ni vigumu kupata vidonge vyenye ubora wa kuaminika. Katika nchi zenye sheria kali za utoaji mimba, watu wengi hutegemea masoko yasiyo rasmi ambapo tembe vinaweza kuwa ghali zaidi na wakati mwingine bandia. Kinyume chake, barani Asia, hasa katika nchi kama India, tembe za utoaji mimba mara nyingi ni nafuu na za kuaminika zaidi.

Tembe za Utoaji Mimba Afrika

Barani Afrika, misoprostol ndiyo dawa ya utoaji mimba inayopatikana zaidi, mara nyingi ikiuza chini ya chapa nyingi katika masoko rasmi na yasiyo rasmi. Vifurushi vilivyosajiliwa vya mchanganyiko vyenye mifepristone vinapatikana katika baadhi ya nchi, lakini havipatikani kwa wingi na vinagawanywa kwa usawa mdogo.

The African continent is illustrated and highlighted in a shade of green.
Uganda
Uganda, Watu hupata zaidi chapa za misoprostol pekee kama Cytotec, Misoclear, Miso-Kare, au Kontrac. Vifurushi vya pamoja kama MA Kare, Divabo, Mariprist, na Medabon hutumika kwa utoaji mimba na huduma ya baada ya kutoa mimba katika hospitali za umma na kliniki zinazosaidiwa na mashirika yasiyo ya kiserikali.
Kenya
Kenya, Chapa za misoprostol pekee kama Cytotec na Miso-Kare zinapatikana kwa wingi. Vifurushi vya pamoja kama Medabon, Ma-Kare, na Mariprist hupatikana kupitia maduka ya dawa na mashirika ya afya ya uzazi, ingawa mara nyingine watumiaji huhitaji cheti cha daktari au ushauri wa kitabibu ili kuzipata.
Ghana na Nigeria
Ghana na Nigeria, Cytotec ndiyo chapa kuu ya misoprostol, ikifuatiwa na Misoclear. Vifurushi vya pamoja kama Medabon na Mariprist hupatikana katika maeneo fulani, hasa kupitia mashirika yasiyo ya kiserikali au mipango rasmi ya uuzaji wa kijamii.
Tanzania
Tanzania, Ingawa misoprostol (mfano Cytotec) inatumika sana (mara nyingi isivyo rasmi), vifurushi vya mchanganyiko havisajiliwi mara kwa mara wala havipatikani rasmi kutokana na vikwazo vya kisheria na ukosefu wa msaada wa sera.
Afrika Magharibi na Kati ya Kifaransa,Chapa za misoprostol kama Cytotec, Misoclear, na dawa za majina ya jumla za ndani (mfano Misodia) ni za kawaida. Vifurushi vya mchanganyiko vyenye uhakika wa ubora, kama Medabon, kifurushi cha pamoja cha China Resources Zizhu, na mara chache Mariprist, vimesajiliwa katika nchi kama Burkina Faso, Côte d’Ivoire, Mali, na Guinea-Bissau..
CHAPA ZA TEMBE ZA UTOAJI MIMBA

Upatikanaji wa chapa duniani kote

Chapa za misoprostol

Cytotec (Pfizer)
Countries
Armenia, Australia, Austria, Azerbaijan, Bahrain, Ubelgiji, Belize, Benin, Bolivia, Burkina Faso, Cambodia, Cameroon, China, Côte d'Ivoire, Jamhuri ya Kidemokrasia ya Kongo, Jamhuri ya Dominika, Ecuador, El Salvador, Finland, Gabon, Georgia, Ghana, Ugiriki, Guatemala, Guinea, Guyana, Iceland, Indonesia, Ireland, Italia, Kenya, Kyrgyzstan, Lebanon, Lithuania, Luxembourg, Mexico, Morocco, Myanmar, Uholanzi, Nigeria, Norway, Peru, Poland, Ureno, Saudi Arabia, Uhispania, Uswidi, Uswisi, Thailand, Togo, Uturuki, Uganda, Uingereza, Marekani, Uzbekistan, Zambia.
Miso‑Fem
Countries
Bolivia, Cameroon, Côte d'Ivoire, Ekuadori, Ethiopia, Ghana, Laos, Liberia, Senegal, Sierra Leone
Misoclear
Countries
Burkina Faso, Cambodia, Cameroon, Côte d'Ivoire, Ghana, Kenya, Liberia, Madagaska, Malawi, Mali, Myanmar, Niger, Nigeria, Senegal, Sierra Leone, Tanzania, Uganda, Zambia, Zimbabwe
Miso‑Kare
Countries
India, Kenya, Sudan Kusini, Tanzania, Uganda
Avertiso
Countries
Benin, Botswana, Cameroon, Mali, Namibia, Nigeria, Uganda, Zimbabwe
Taneciprol
Countries
Jamhuri ya Dominika, El Salvador, Guatemala, Honduras, Mexico
Misoprostol (Naari)
Countries
Chile, Kenya, Myanmar, Nigeria, Peru, Tanzania, Sudan Kusini
Prostokos
Countries
Brazil
Misotrol
Countries
Chile na Amerika ya Kusini
Misofar
Countries
Albania, Angola, Jamhuri ya Kongo, Côte d'Ivoire, Jamhuri ya Dominika, El Salvador, Guinea, Honduras, Lebanon, Madagaska, Mali, Mauritania, Moldova, Msumbiji, Uhispania
Oxaprost®
Countries
Argentina

Paki ya mchanganyiko wa mifepristone na misoprostol:

Unwanted- Kit (Mankind Pharma)
Countries
India
Composition
MA Kare
Countries
Uganda, Kenya
Composition
Medabon (Sun Pharma):
Countries
Argentina, Barbados, Belarus, Belize, Benin, Bolivia, Burkina Faso, Cambodia, Ethiopia, Ghana, Kazakhstan, Kenya, Kyrgyzstan, Laos, Moldova, Msumbiji, Masedonia Kaskazini, Romania, Afrika Kusini, Sudan, Thailand, Tunisia, Uingereza, Vietnam, Zambia
Composition
China Zizhu co‑pack:
Countries
Burkina Faso, Guinea-Bissau, Msumbiji, São Tomé na Príncipe, Zimbabwe
Composition
Divabo
Countries
Cambodia, Uganda, Zambia
Composition
Mariprist
Countries
Burkina Faso, Cambodia, Côte d'Ivoire, Ghana, Kenya, Liberia, Sierra Leone, Uganda, Uruguay, Zambia, Zimbabwe
Composition

Mifepristone inauzwa peke yake:

Mediprist
Countries
Uganda
Mifepristone LinePharma
Countries
Bolivia, Kolombia
Mifetril
Countries
Uganda
Mifegest
Countries
India

Je, ungependa taarifa kuhusu chapa zinazopatikana katika nchi yako? Tembelea MedAb.org kwa maelezo zaidi kulingana na nchi au wasiliana na washauri wetu.

Chunguza Makala Zetu Za Hivi Punde

Gundua makala zetu kwa maelezo zaidi kuhusu utoaji mimba kwa kutumia tembe.

Mawasiliano na Msaada

Pata Msaada: Zungumza na Mshauri Aliyefunzwa Kuhusu Utoaji Mimba

Tunatoa taarifa zenye ushahidi kuhusu utoaji mimba salama. Huduma yetu ya ushauri nasaha ni salama, ya siri, rahisi, na haina hukumu yoyote. Tunangojea ujumbe wako!

Vyanzo na Utaalamu wa Matibabu ulio nyuma ya taarifa hizi

imeandaliwa na timu ya safe2choose pamoja na msaada wa wataalamu toka carafem, kulingana na Miongozo ya Huduma ya Utoaji Mimba ya WHO ya mwaka 2022; Sasisho za Kliniki za Afya ya Uzazi za mwaka 2023 kutoka Ipas na Miongozo ya Sera za Kliniki kwa Huduma ya Utoaji Mimba ya NAF ya mwaka 2024.

safe2choose inaungwa mkono na Bodi ya Ushauri ya Matibabu inayoundwa na wataalamu wakuu wa Afya ya Uzazi na Haki za Uzazi.

carafem inatoa huduma za utoaji mimba na uzazi wa mpango kwa njia rahisi na za kitaalamu ili watu waweze kudhibiti idadi na muda wa kupata watoto.

Ipas ni shirika la kimataifa linalolenga kuongeza upatikanaji wa huduma salama za utoaji mimba na kinga ya uzazi.

WHO ni shirika la Umoja wa Mataifa linalohusika na Afya ya umma duniani.

NAF ni shirika la kitaalamu nchini Marekani linalounga mkono huduma salama za utoaji mimba zinazozingatia ushahidi na haki za uzazi.

[1] "Abortion care guideline." World Health Organization, 2022, srhr.org/abortioncare/.

[2] Jackson, E. "Clinical Updates in Reproductive Health." Ipas, 2023, www.ipas.org/wp-content/uploads/2023/09/Ipas-Clinical-Updates-in-Reproductive-Health-CURHE23b.pdf.

[3]"Clinical Policy Guidelines." National Abortion Federation, 2024, prochoice.org/providers/quality-standards/.

[4] Platais, I., et al. "Prospective study of home use of mifepristone and misoprostol for medical abortion up to 10 weeks of pregnancy in Kazakhstan." International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2016;134(3): 268–271, www.ncbi.nlm.nih.gov/pubmed/?term=Prospective+study+of+home+use+of+mifepristone+and+misoprostol+for+medical+abortion+up+to+10+weeks+of+pregnancy+in+Kazakhstan. Accessed May 2025.

[5] Raymond, E. G., Harrison, M. S., & Weaver, M. A. ""Efficacy of Misoprostol Alone for First-Trimester Medical Abortion: A Systematic Review."" Gynuity Health Projects, 2019, gynuity.org/resources/efficacy-of-misoprostol-alone-for-first-trimester-medical-abortion-a-systematic-review. Accessed May 2025.

[6] Consorcio Latinoamericano Contra el Aborto Inseguro (CLACAI). Mifepristona y misoprostol en seis países de América Latina: procesos de registro y disponibilidad. Enero 2017, Lima, Perú. Retrieved from: https://clacaidigital.info/bitstream/handle/123456789/1000/Mifepristona%20y%20misoprostol%20en%20seis%20paises%20de%20America%20Latina.%20CLACAI%202017.pdf?sequence=1&isAllowed=y

[7] WHO Expert Committee on Selection and Use of Essential Medicines. The Selection and Use of Essential Medicines 2023: Executive Summary of the Report of the 24th WHO Expert Committee on Selection and Use of Essential Medicines. World Health Organization, 2023, who.int/publications/i/item/WHO-MHP-HPS-EML-2023.01 Accessed Aug. 2025.

[8] Sedgh, G., & Taqi, I. Mifepristone for Abortion in a Global Context: Safe, Effective and Approved in Nearly 100 Countries. Guttmacher Institute, 2023, guttmacher.org/2023/07/mifepristone-abortion-global-context-safe-effective-and-approved-nearly-100-countries. Accessed Aug. 2025.

[9] MedAb.org. Research and Analysis. MedAb, n.d., medab.org/research-analysis. Accessed Aug. 2025.

[10] Durocher, J., Kilfedder, C., Frye, L. J., Winikoff, B., & Srinivasan, K. A Descriptive Analysis of Medical Abortion Commodity Availability and Pricing at Retail Outlets in 44 Countries Across Four Regions Globally. Taylor & Francis Online, 2021, tandfonline.com/doi/full/10.1080/26410397.2021.1982460. Accessed Aug. 2025.

[11] IPPF (International Planned Parenthood Federation). Abortion Commodities Database. IPPF Medical Abortion Commodities Database, n.d., medab.org/search. Accessed Aug. 2025.